Matthew Harrison
Stock Analyst at Morgan Stanley
(3.38)
# 979
Out of 4,711 analysts
750
Total ratings
47.25%
Success rate
3.28%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALEC Alector | Downgrades: Underweight | $10 → $3 | $1.86 | +61.29% | 10 | Nov 26, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $473 → $476 | $397.27 | +19.82% | 36 | Nov 5, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $1,235 → $1,184 | $701.85 | +68.70% | 50 | Nov 1, 2024 | |
| BIIB Biogen | Downgrades: Equal-Weight | $285 → $204 | $146.47 | +39.28% | 50 | Oct 31, 2024 | |
| AVNT Avient | Downgrades: Neutral | n/a | $41.50 | - | 1 | Oct 18, 2024 | |
| IOBT IO Biotech | Maintains: Overweight | $4 → $6 | $0.77 | +678.21% | 5 | Sep 16, 2024 | |
| AVIR Atea Pharmaceuticals | Upgrades: Equal-Weight | $2 → $6.88 | $3.19 | +115.67% | 9 | Aug 13, 2024 | |
| TSVT 2seventy bio | Maintains: Equal-Weight | $7 → $6 | $3.14 | +91.08% | 9 | Jul 29, 2024 | |
| INSM Insmed | Maintains: Overweight | $60 → $85 | $70.44 | +20.67% | 15 | Jul 12, 2024 | |
| SRPT Sarepta Therapeutics | Maintains: Overweight | $165 → $200 | $118.97 | +68.11% | 34 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $17.16 | -35.90% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $3.00 | +166.67% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $623.82 | -18.25% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $1.31 | +434.35% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $78 | $92.57 | -15.74% | 37 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $65.66 | +70.58% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $19.57 | +73.74% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $20.31 | +57.56% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $319 | $176.50 | +80.74% | 27 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $2.90 | +555.17% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $14 | $1.67 | +738.32% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $128 → $123 | $39.39 | +212.26% | 23 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $65 → $85 | $34.08 | +149.41% | 10 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underweight | $60 | $8.50 | +605.88% | 30 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $38.22 | +20.36% | 1 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $61 → $63 | $21.45 | +193.71% | 11 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $1.70 | +664.71% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.44 | +125.28% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $17.84 | -43.95% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $4.35 | +83.91% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $26.76 | +64.42% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $1.65 | +687.88% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $4 | $0.61 | +552.85% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $3 | $0.50 | +500.00% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $113.08 | +91.02% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $1.96 | +155.10% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.05 | +143.90% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $175.58 | +3.66% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $8.65 | +4.05% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $29.34 | +36.33% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $263.38 | +7.07% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $245.44 | -14.44% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $32 → $27 | $0.40 | +6,583.17% | 7 | Sep 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $26.36 | +97.27% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $144.47 | +19.75% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $5.61 | +916.04% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $44.22 | +171.37% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $36.26 | +308.16% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $98.05 | -16.37% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $57.33 | +15.12% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $1.85 | +2,008.11% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $24.92 | +84.59% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $14.58 | +140.05% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $767.76 | -64.18% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $1.77 | +973.45% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $7.62 | +713.65% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.32 | +5.70% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $0.96 | +5,109.42% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $68.84 | +20.57% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $57 | $15.52 | +267.27% | 4 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $48.87 | -79.54% | 4 | Sep 10, 2018 |
Alector
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.86
Upside: +61.29%
Vertex Pharmaceuticals
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $473 → $476
Current: $397.27
Upside: +19.82%
Regeneron Pharmaceuticals
Nov 1, 2024
Maintains: Overweight
Price Target: $1,235 → $1,184
Current: $701.85
Upside: +68.70%
Biogen
Oct 31, 2024
Downgrades: Equal-Weight
Price Target: $285 → $204
Current: $146.47
Upside: +39.28%
Avient
Oct 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $41.50
Upside: -
IO Biotech
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $0.77
Upside: +678.21%
Atea Pharmaceuticals
Aug 13, 2024
Upgrades: Equal-Weight
Price Target: $2 → $6.88
Current: $3.19
Upside: +115.67%
2seventy bio
Jul 29, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $3.14
Upside: +91.08%
Insmed
Jul 12, 2024
Maintains: Overweight
Price Target: $60 → $85
Current: $70.44
Upside: +20.67%
Sarepta Therapeutics
Jun 24, 2024
Maintains: Overweight
Price Target: $165 → $200
Current: $118.97
Upside: +68.11%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $17.16
Upside: -35.90%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $3.00
Upside: +166.67%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $623.82
Upside: -18.25%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $1.31
Upside: +434.35%
Apr 26, 2024
Maintains: Equal-Weight
Price Target: $80 → $78
Current: $92.57
Upside: -15.74%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $65.66
Upside: +70.58%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $19.57
Upside: +73.74%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $20.31
Upside: +57.56%
Aug 29, 2023
Maintains: Overweight
Price Target: $321 → $319
Current: $176.50
Upside: +80.74%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $2.90
Upside: +555.17%
Aug 10, 2023
Maintains: Overweight
Price Target: $13 → $14
Current: $1.67
Upside: +738.32%
Aug 4, 2023
Maintains: Equal-Weight
Price Target: $128 → $123
Current: $39.39
Upside: +212.26%
Jul 20, 2023
Maintains: Overweight
Price Target: $65 → $85
Current: $34.08
Upside: +149.41%
Jul 11, 2023
Reiterates: Underweight
Price Target: $60
Current: $8.50
Upside: +605.88%
Apr 24, 2023
Reiterates: Buy
Price Target: $46
Current: $38.22
Upside: +20.36%
Apr 12, 2023
Maintains: Overweight
Price Target: $61 → $63
Current: $21.45
Upside: +193.71%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $1.70
Upside: +664.71%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.44
Upside: +125.28%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $17.84
Upside: -43.95%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $4.35
Upside: +83.91%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $26.76
Upside: +64.42%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $1.65
Upside: +687.88%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $4
Current: $0.61
Upside: +552.85%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $5 → $3
Current: $0.50
Upside: +500.00%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $113.08
Upside: +91.02%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $1.96
Upside: +155.10%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $2.05
Upside: +143.90%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $175.58
Upside: +3.66%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $8.65
Upside: +4.05%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $29.34
Upside: +36.33%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $263.38
Upside: +7.07%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $245.44
Upside: -14.44%
Sep 9, 2022
Maintains: Overweight
Price Target: $32 → $27
Current: $0.40
Upside: +6,583.17%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $26.36
Upside: +97.27%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $144.47
Upside: +19.75%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $5.61
Upside: +916.04%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $44.22
Upside: +171.37%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $36.26
Upside: +308.16%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $98.05
Upside: -16.37%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $57.33
Upside: +15.12%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $1.85
Upside: +2,008.11%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $24.92
Upside: +84.59%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $14.58
Upside: +140.05%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $767.76
Upside: -64.18%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $1.77
Upside: +973.45%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $7.62
Upside: +713.65%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.32
Upside: +5.70%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $0.96
Upside: +5,109.42%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $68.84
Upside: +20.57%
Oct 11, 2018
Maintains: Overweight
Price Target: $59 → $57
Current: $15.52
Upside: +267.27%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $48.87
Upside: -79.54%